Related Experiment Video
Updated: Oct 5, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic Value of the Pattern of Non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) Bleeding Risk
Joh Akama1, Takeshi Shimizu1, Takuya Ando1
1Department of Cardiovascular Medicine, Fukushima Medical University.
Insights
The Patterns of non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) bleeding risk score predicts outcomes after percutaneous coronary intervention (PCI). High-risk patients face significantly higher mortality, indicating its prognostic value.
Area of Science:
- Cardiology
- Clinical Research
- Outcomes Research
Background:
- The Patterns of non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) bleeding risk score is used to predict bleeding after percutaneous coronary intervention (PCI).
- The prognostic value of the PARIS score for long-term mortality and heart failure hospitalization post-PCI remains unevaluated.
Purpose of the Study:
- To assess the prognostic capability of the PARIS bleeding risk score for predicting all-cause mortality, cardiac mortality, and heart failure hospitalization in patients following PCI.
Main Methods:
- A prospective study involving 1061 consecutive patients undergoing PCI.
- Patients were stratified into low, intermediate, and high-risk groups based on the PARIS score.
- Outcomes including all-cause mortality, cardiac mortality, and heart failure hospitalization were tracked.
Main Results:
- Kaplan-Meier analysis showed the highest rates of all-cause mortality, cardiac mortality, and heart failure hospitalization in the high-risk PARIS score group (P < 0.001 for all).
- Multivariable Cox analysis indicated that intermediate and high-risk groups had significantly higher all-cause mortality compared to the low-risk group (aHR 6.06, P=0.013 and aHR 12.50, P<0.001, respectively).
Conclusions:
- The PARIS bleeding risk score is a significant predictor of all-cause mortality in patients after PCI.
- The PARIS score demonstrates prognostic value beyond bleeding risk, extending to overall survival in stented patients.
Abstract:
The Patterns of non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) bleeding risk score has been proposed to predict the risk of bleeding events after percutaneous coronary intervention (PCI). However, the prognostic value of the PARIS bleeding risk score for long term all-cause mortality, cardiac mortality and hospitalization due to heart failure has not yet been evaluated. Therefore, the aim of the present study was to evaluate the prognostic value of the PARIS bleeding risk score for all-cause and cardiac mortalities and hospitalization due to heart failure after PCI. Consecutive 1061 patients who had undergone PCI were divided into 3 groups based on the PARIS bleeding risk score; low (n = 112), intermediate (n = 419) and high-risk groups (n = 530). We prospectively followed up the 3 groups for all-cause and cardiac mortalities and hospitalization due to heart failure. Kaplan-Meier analysis revealed that all of the outcomes were highest in the high-risk group among the 3 groups (P < 0.001, P < 0.001 and P < 0.001 respectively). Multivariable Cox proportional hazard analysis, adjusted for confounding factors, revealed that all-cause mortality of the intermediate or high-risk groups was higher than those of the low-risk group (adjusted hazard ratio 6.06 and 12.50, P = 0.013 and P < 0.001, respectively). The PARIS bleeding risk score is a significant indicator of prognosis for all-cause mortality in patients after PCI.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation